Fetal epigenetic programming of adipokines

Area of Science:

• Epigenetics and its role in complex traits.
• Maternal health and fetal development.
• Metabolic programming and disease risk.

Background:

• Complex traits like obesity and diabetes are areas of significant research interest.
• Epigenetic mechanisms, such as DNA methylation, are increasingly recognized for their role in gene regulation.
• Maternal hyperglycemia during pregnancy is a known risk factor for adverse pregnancy outcomes and potential long-term health issues in offspring.

Purpose of the Study:

• To investigate epipolymorphisms in placental leptin and adiponectin genes in relation to maternal hyperglycemia.
• To explore the role of DNA methylation in fetal metabolic programming.
• To discuss the significance of adipokine epigenetic modifications in the context of later-life obesity and diabetes risk.

Main Methods:

• Identification of epipolymorphisms in placental leptin and adiponectin genes.
• Analysis of DNA methylation patterns in relation to maternal hyperglycemia.
• Comparison of methylation variations across different tissues and cell types (preliminary data).

Main Results:

• Reported several epipolymorphisms in placental leptin and adiponectin genes associated with maternal hyperglycemia.
• Findings suggest DNA methylation may partially mediate the link between adverse fetal environment exposure and later-life obesity/diabetes risk.
• Preliminary data indicate similarities in methylation variations across different tissues and cell types.

Conclusions:

• Epigenetic alterations in adipokines (leptin and adiponectin) are potentially important in fetal metabolic programming.
• DNA methylation in placental genes could be a key mechanism linking early-life environmental exposures to chronic disease risk.
• Further research is needed to understand the challenges and perspectives in this emerging field of adipokine epigenetic modifications.